Economic Burden of Chronic Obstructive Pulmonary Disease Patients in Malaysia: A Longitudinal Study

Anees Ur Rehman1, Mohamed Azmi Hassali1, Sohail Ayaz Muhammad2, Sadia Shakeel1, Siew Chin Ong3, Irfhan Ali Bin Hyder Ali4, Jaya Muneswarao1, Rabia Hussain3
1Department of Clinical Pharmacy, School of Pharmaceutical Sciences, University Sains Malaysia, Penang, Malaysia
2School of Management Sciences, University Sains Malaysia, Penang, Malaysia
3Department of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, University Sains Malaysia, Penang, Malaysia
4Respiratory Department, Hospital Pulau Penang, Ministry of Health Malaysia, Penang, Malaysia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–50.

Lim S, Lam DCL, Muttalif AR, Yunus F, Wongtim S, Shetty V, et al. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pacific Fam Med. 2015;14(1):4.

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.

Hassan HA, Aziz NA, Hassan Y, Hassan F. Does the duration of smoking cessation have an impact on hospital admission and health-related quality of life amongst COPD patients? Int J Chron Obstr Pulmonary Dis. 2014;9:493.

Board MHP. ITC Malaysia National Report: findings from Wave 1 to 4 surveys (2005–2009). 2012. Available at: https://www.mysihat.gov.my/v2/promosi/images/stories/pusatmaklumat/itcreport. Accessed Sep 2019.

Shahab L, Jarvis M, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12):1043–7.

WHO. World Health Statistics 2018. World Health Organization. 2019. Available at: https://apps.who.int/iris/bitstream/handle/10665/272596/9789241565585-eng.pdf.

D'Souza AO, Shah M, Dhamane AD, Dalal AA. Clinical and economic burden of COPD in a medicaid population. COPD. 2014;11(2):212–20.

ur Rehman A, Ahmad Hassali MA, Muhammad SA, Shah S, Abbas S, Hyder Ali IAB, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in USA, Europe and Asia: results from a systematic review of the literature. Expert Rev Pharmacoecon Outcomes Res. Epub 18 Oct 2019.

Shah S, Abbas G, Hanif M, Rehman A, Zaman M, Riaz N, et al. Increased burden of disease and role of health economics: Asia-pacific region. Expert Rev Pharmacoecon Outcomes Res. 2019;19(5):517–28.

Ding D, Kolbe-Alexander T, Nguyen B, Katzmarzyk PT, Pratt M, Lawson KD. The economic burden of physical inactivity: a systematic review and critical appraisal. Br J Sports Med. 2017;51(19):1392–409.

WHO. Measurement of Healthy Life Expectancy and Wellbeing. Geneva: World Health Organization; 2019. Available at: https://www.who.int/healthinfo/sage/meeting_reports/en/.

Rai KK, Adab P, Ayres JG, Siebert WS, Sadhra SS, Sitch AJ, et al. Factors associated with work productivity among people with COPD: Birmingham COPD Cohort. Occup Environ Med. 2017;74(12):859–67.

Holden L, Scuffham PA, Hilton MF, Ware RS, Vecchio N, Whiteford HA. Which health conditions impact on productivity in working Australians? J Occup Environ Med. 2011;53(3):253–7.

daCosta DM, Paulose-Ram R, Su J, McDonald M, Zou KH, Wagner J-S, et al. The burden of chronic obstructive pulmonary disease among employed adults. Int J Chron Obstr Pulmonary Dis. 2012;7:211.

Thornton Snider J, Romley JA, Wong KS, Zhang J, Eber M, Goldman DP. The disability burden of COPD. COPD. 2012;9(5):513–21.

May SM, Li JT, editors. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy and asthma proceedings: OceanSide Publications; 2015.

Rehman A, Hassali MAA, Muhammad SA, Harun SN, Shah S, Abbas S. The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. Eur J Health Econ. 2020;21(2):181–94. https://doi.org/10.1007/s10198-019-01119-1.

Rehman A, Hassali MAA, Abbas S, Ali IABH, Harun SN, Muneswarao J, et al. Pharmacological and non-pharmacological management of COPD limitations and future prospects: a review of current literature. J Public Health. 2019. https://doi.org/10.1007/s10389-019-01021-3.

Quek D (ed). The Malaysian healthcare system: a review. Intensive workshop on health systems in transition. 2009; Kuala Lumpur.

Krol M, Papenburg J, van Exel J. Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies. Pharmacoeconomics. 2015;33(2):123–35.

Goodrich K, Kaambwa B, Al-Janabi H. The inclusion of informal care in applied economic evaluation: a review. Value Health. 2012;15(6):975–81.

Department of Statistics Malaysia. Household Income & Expenditure. 2019. Available at: https://www.dosm.gov.my/v1/index.php?r=column/ctwoByCat&parent_id=119&menu_id=amVoWU54UTl0a21NWmdhMjFMMWcyZz09.

Exchange Rates, Central Bank of Malaysia. Government of Malaysia, Malaysia. Available at: https://www.bnm.gov.my/index.php?ch=statistic&pg=stats_exchangerates. Accessed 18 Sep 2019.

Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43.

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373–83.

Cohen MD, Hawes DR, Hutchins GD, McPhee WD, LaMasters MB, Fallon RP. Activity-based cost analysis: a method of analyzing the financial and operating performance of academic radiology departments. Radiology. 2000;215(3):708–16.

Malaysia Go. Public Service Department. 2019. Available at: https://www.jpa.gov.my/index.php?option=com_content&view=article&id=44%3Acirculars-list-2007&catid=39%3Acirculars-list&lang=ms. Accessed Sep 2019.

Consumer Price Guide, Pharmaceutical Services Program, Ministry of Health Malaysia. Available at:. https://www.pharmacy.gov.my/v2/en/apps/drug-price. Accessed 1 Sep 2019.

WHO. Cost effectiveness and strategic planning, Word Health Organization. 2019. Available at: https://www.who.int/choice/cost-effectiveness/inputs/capital_goods/en/. Accessed Sep 2019.

Atif M, Sulaiman SAS, Shafie AA, Asif M. Resource utilization pattern and cost of tuberculosis treatment from the provider and patient perspectives in the state of Penang, Malaysia. BMC Health Serv Res. 2014;14(1):353.

Barnes N, Calverley PM, Kaplan A, Rabe KF. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global hidden depths of COPD survey. BMC Pulmonary Med. 2013;13(1):54.

Rehman A, Naeem F, Abbas S, Ashfaq F, Hassali MAA. Utilization of short message service (SMS) in non-pharmacological management of hypertension. A pilot study in an URBAN public hospital of Multan Pakistan. J Public Health. 2019;27(5):561–7.

Colás C, Brosa M, Antón E, Montoro J, Navarro A, Dordal M, et al. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study. Allergy. 2017;72(6):959–66.